A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Public ClinicalTrials.gov record NCT07804615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Vista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy. The main objectives of this clinical trial are to determine the following: * Does VIM0423 therapy improve tremor symptoms in adults with Parkinson's disease? * Is VIM0423 well tolerated in individuals with Parkinsons's disease? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?
Study identification
- NCT ID
- NCT07804615
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
- Last update posted
- Sep 3, 2026
2026 – 2027
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vima Site #039 | Scottsdale | Arizona | 85251 | — |
| Vima Site #064 | Scottsdale | Arizona | 85258 | — |
| Vima Site #048 | Murrieta | California | 92562 | — |
| Vima Site #050 | Stamford | Connecticut | 06905 | — |
| Vima Site #065 | Altamonte Springs | Florida | 32714 | — |
| Vima Site #054 | Aventura | Florida | 33180 | — |
| Vima Site #008 | Miami | Florida | 33176 | — |
| Vima Site #046 | Naples | Florida | 34105 | — |
| Vima Site #053 | Palm Beach | Florida | 33407 | — |
| Vima Site #062 | Tampa | Florida | 33602 | — |
| Vima Site #047 | Atlanta | Georgia | 30328 | — |
| Vima Site #045 | Decatur | Georgia | 30030 | — |
| Vima Site #041 | Overland Park | Kansas | 66211 | — |
| Vima Site #043 | Baltimore | Maryland | 21237 | — |
| Vima Site #007 | Olney | Maryland | 20832 | — |
| Vima Site #002 | Farmington Hills | Michigan | 48334 | — |
| Vima Site #014 | Albuquerque | New Mexico | 87106 | — |
| Vima Site #055 | Amherst | New York | 14226 | — |
| Vima Site #024 | New York | New York | 10019 | — |
| Vima Site #052 | Patchogue | New York | 11772 | — |
| Vima Site #067 | Raleigh | North Carolina | 27607 | — |
| Vima Site #051 | Canton | Ohio | 44718 | — |
| Vima Site #016 | Memphis | Tennessee | 38157 | — |
| Vima Site #049 | Cypress | Texas | 77429 | — |
| Vima Site #063 | Dallas | Texas | 75243 | — |
| Vima Site #058 | Round Rock | Texas | 78681 | — |
| Vima Site #066 | Arlington | Virginia | 22205 | — |
| Vima Site #023 | Kirkland | Washington | 98034 | — |
| Vima Site #015 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07804615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07804615 live on ClinicalTrials.gov.